04 September 2014

EuroQSAR-2014: results of the work

Today in St. Petersburg, the work is being completed
European Symposium on computer-aided drug design

Marina Astvatsaturyan, Echo of MoscowFor more than 40 years of existence of the "European Symposium on the Analysis of Quantitative Relationships 'Structure-Activity'" (EuroQSAR), which is held regularly in different countries of the Old World, Russia has become the host country for the first time.

The general idea of the twentieth anniversary symposium EUROXAR-2014 is understanding chemical–biological interactions. About 260 reputable specialists and young researchers from 38 countries took part in its scientific sessions.

The plenary reports at the symposium were made by well-known scientists in the professional community from the USA, Great Britain, Switzerland, Austria, Belgium, Germany, Spain, Sweden and Russia. And the symposium was opened by a lecture by Toshio Fujita, Professor of Kyoto University of Japan, who, together with American scientist Corvin Hansch, published an article in 1964 in the Journal of the American Chemical Society, which was subsequently cited more than 2000 times and laid the foundation for modern approaches to computer modeling of medicines.

"It is known that the creation of a new drug is a long and expensive process, on average requiring 14 years of work "from idea to pharmacy" and financial costs reaching three billion US dollars. At the same time, about 10,000 different molecules of organic compounds are tested in the course of research and development to bring one drug to the market," Professor Vladimir Poroikov, chairman of the organizing committee of the symposium, head of the Department of bioinformatics and the laboratory of structural and functional design of drugs of the Russian Academic Institute of Biomedical Chemistry, explained to the audience of Echo of Moscow.

"The use of computer–aided drug design methods can significantly reduce time and financial costs, reduce the risks of negative results and the number of animal tests," Professor Poroikov stressed.

Developments in the field of computer design of biologically active substances have applications not only in pharmacology, but also in agrochemistry and environmental protection. Within the framework of the symposium, a School of young Russian scientists on methods of computer design of medicines was held on the basis of the St. Petersburg Chemical and Pharmaceutical Academy from August 28 to 30. Experienced lecturers – participants of the EUROXAR-2014 symposium spoke to 130 students and postgraduates from various regions of Russia. Seminars were held to demonstrate freely and commercially available information software for computer-based drug design, which can also be used by academic researchers.

Portal "Eternal youth" http://vechnayamolodost.ru04.09.2014

Found a typo? Select it and press ctrl + enter Print version